All Deals
March 7, 2025 - Deals
Flowdesk Secures $102M Funding From HV Capital, Eurazeo, Cathay Innovation, ISAI And BlackRock
Flowdesk, a NYC-based digital asset trading and technology firm, raised $102M in equity funding from HV Capital, Eurazeo, Cathay Innovation, ISAI, and a debt facility managed by BlackRock. Founded in 2020 and led by CEO Guilhem Chaumont, Flowdesk provides liquidity and OTC trading solutions, leveraging algorithmic trading and proprietary technology to enhance transparency in digital asset markets. The funds will be used to scale its OTC derivatives business and launch a dedicated crypto credit desk.
INVESTORS: HV Capital, Eurazeo, Cathay Innovation, ISAI & BlackRock
AMOUNT: $102,000,000
HQ: #NewYork #NY #NewYorkCity #NYC
#VentureCapital #Flowdesk #GuilhemChaumont #HVCapital #Eurazeo #CathayInnovation #ISAI #BlackRock #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC